Total Funding
73
52
Total FundingSeries D raised
Growth Score
-15 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
56387
Heartseed is a clinical- stage biotechnology firm that focuses on utilizing regenerative medicine to address heart disease.
- Takano June: Chief Financial Officer
- Kikuo Yasui: Director and Chief Operating Officer
About the Company
Heartseed is a biotechnology research firm that specializes in the development of purified ventricular cardiomyocytes derived from induced pluripotent stem cells for the treatment of heart failure. The company employs an innovative methodology that involves the creation of cardiomyocyte spheroids, small clusters of heart cells, using stem cells.
These spheroids are then surgically implanted into the heart to improve its performance.
